Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05769556 Completed - Down Syndrome Clinical Trials

Effect Of Brain Gym Exercises On Postural Stability In Children With Down Syndrome

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

This study will be conducted to detect the effect of brain gym exercises on postural stability in children with down syndrome .

NCT ID: NCT05768724 Completed - Obesity Clinical Trials

Two Different Dietary Interventions for Girls With Polycystic Ovary Syndrome

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This study was conducted to evaluate the efficacy of the MEtabolic Syndrome REduction in NAvarra (RESMENA) diet versus a control diet based on American Heart Association (AHA) recommendations for the treatment of PCOS in adolescents with obesity and PCOS. A total of 40 adolescents diagnosed with PCOS between the ages of 13-18 years were randomized to either a Resmena or control diet for 6 months. Dietary status, anthropometry, body composition, biochemical parameters, and reproductive endocrine hormones were compared between the 2 groups before and after the intervention.

NCT ID: NCT05765591 Completed - Clinical trials for Post-COVID-19 Syndrome

Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome

Start date: March 29, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled study is to evaluate the effects of balneotherapy (BT) and aquatic exercises in patients with post-acute COVID syndrome (PACS). The main question it aims to answer are: • Does BT and aquatic exercises alleviate some of the most prevalent features that characterize post-acute COVID syndrome? Participants allocated to the intervention group will undergo 3 weekly sessions of BT and aquatic exercises on alternate days in groups of 8 during 4 weeks. Prior the beginning of the intervention, patients were asked to complete an array of validated self-reported questionnaires that covered an important part of PACS symptomatology. These patients were asked to complete these same questionnaires immediately after completing the intervention and one month after. They were also asked to report adverse events associated to the intervention. Patients allocated to the control group were asked to complete the same questionnaires at baseline and one and two months post-baseline. They were instructed to not enroll in any kind of BT-related activities during the duration of the study. Questionnaires were analyzed and compared between groups to assess the effects of the intervention.

NCT ID: NCT05765305 Completed - Clinical trials for Polycystic Ovary Syndrome

Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Start date: September 1, 2018
Phase:
Study type: Observational

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

NCT ID: NCT05764070 Completed - Clinical trials for Post-COVID-19 Syndrome

Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients

Start date: March 9, 2023
Phase: N/A
Study type: Interventional

Chronic fatigue, weakness, dyspnea, headaches, cognitive dysfunction, stress, sadness, anxiety, sleep disturbances, and orthostatic intolerance are among the symptoms of acute Covid-19 in patients, and these symptoms persist for more than 12 weeks after recovery. Extended Covid-19 syndrome, also known as Post-Covid-19 syndrome, is described as

NCT ID: NCT05761626 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Mechanical Power and Ventilatory Ratio in ARDS

Start date: March 1, 2016
Phase:
Study type: Observational

Mechanical power (MP) and ventilatory ratio (VR) are variables associated with outcomes in patients with acute respiratory distress syndrome (ARDS). In respiratory setting, the optimization of MP should lead to an increase in VR. Therefore, the objectives of this study are: to assess the relationship between MP and VR and to compare the components of MP (ventilatory variables) according to a level of MP (17 J/minute) considered harmful.

NCT ID: NCT05761184 Completed - Clinical trials for Prader-Willi Syndrome

Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)

PROTEOMARKER
Start date: April 28, 2022
Phase:
Study type: Observational

The lack of serum markers that can be used to identify the levels of steatosis in obese subjects, or that can indicate a rapid progression of the metabolic disease, in which it is very often difficult to perform analyzes with imaging techniques, limits the current evolution from a generalized medicine to a personalized medicine. With the project proposal the aim is to identify serum markers for the characterization of steatosis in subjects affected by genetic obesity, which will most likely also be used in metabolic obesity.

NCT ID: NCT05755646 Completed - Breast Cancer Clinical Trials

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial

WIn-HFS
Start date: March 10, 2023
Phase: N/A
Study type: Interventional

The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.

NCT ID: NCT05751070 Completed - Neck Syndrome Clinical Trials

Bowen and Graston Technique in Patients of Tension Neck Syndrome

Start date: March 16, 2023
Phase: N/A
Study type: Interventional

To compare the effects of Bowen and Graston technique in Tension neck syndrome for neck pain , ROM and disability in patients with Tension neck syndrome .

NCT ID: NCT05750758 Completed - Clinical trials for Acute Coronary Syndrome

Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

The target population of this interventional study was ACS patients with drug-coated balloons. The main discussion : 1.1 months of rivaroxaban combined with dual antiplatelet therapy compared with dual antiplatelet therapy alone, late lumen loss at 6 months. 2. To determine the safety of the regimen with bleeding events as the end point. Subjects were randomly assigned to two groups, one receiving routine DAPT for six months and one receiving DAPT plus one month of rivaroxaban 2.5 mg bid